The effects of a cyclooxygenase-2 (COX-2) expression and inhibition on human uveal melanoma cell proliferation and macrophage nitric oxide production

Journal of Carcinogenesis

Volumn 6, Issue , 2007, Pages

  Marshall, Jean Claude ^a   Caissie, Amanda L ^a   Cruess, Stephanie R ^a   Cools Lartigue, Jonathan ^a   Burnier Jr , Miguel N ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMFENAC; CYCLOOXYGENASE 2; NEPAFENAC; NITRIC OXIDE;

ARTICLE; CELL CULTURE; CELL FUNCTION; CELL PROLIFERATION; CONTROLLED STUDY; CULTURE MEDIUM; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MACROPHAGE; MELANOMA CELL; PROTEIN EXPRESSION; PROTEIN FUNCTION; UVEA MELANOMA;

EID: 38949149312     PISSN: None     EISSN: 14773163     Source Type: Journal    
DOI: 10.1186/1477-3163-6-17     Document Type: Article

References (38)

1. Chang M Zimmerman LE McLean I The persisting pseudomelanoma problem Arch Ophthalmol 1984, 102(5):726-727 6721764
2. COMS Accuracy of diagnosis of choroidal melanomas in the Collaborative Ocular Melanoma Study. COMS report no. 1 Arch Ophthalmol 1990, 108(9):1268-1273 2205183
3. Diener-West M Earle JD Fine SL Hawkins BS Moy CS Reynolds SM Schachat AP Straatsma BR The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma, III: Initial mortality findings. COMS Report No. 18 Arch Ophthalmol 2001, 119(7):969-982 11448319
4. Diener-West M Hawkins BS Markowitz JA Schachat AP A review of mortality from choroidal melanoma. II. A meta-analysis of 5-year mortality rates following enucleation, 1966 through 1988 Arch Ophthalmol 1992, 110(2):245-250 1531290
5. Makitie T Summanen P Tarkkanen A Kivela T Tumor-infiltrating macrophages (CD68(+) cells) and prognosis in malignant uveal melanoma Invest Ophthalmol Vis Sci 2001, 42(7):1414-1421 11381040
6. Duff M Stapleton PP Mestre JR Maddali S Smyth GP Yan Z Freeman TA Daly JM Cyclooxygenase-2 inhibition improves macrophage function in melanoma and increases the antineoplastic activity of interferon gamma Ann Surg Oncol 2003, 10(3):305-313 10.1245/ASO.2003.04.033 12679317
7. Figueiredo A Caissie AL Callejo SA McLean IW Gold P Burnier MN Jr. Cyclooxygenase-2 expression in uveal melanoma: Novel classification of mixed-cell-type tumours Can J Ophthalmol 2003, 38(5):352-356 12956275
8. Smith WL DeWitt DL Garavito RM Cyclooxygenases: Structural, cellular, and molecular biology Annu Rev Biochem 2000, 69:145-182 10.1146/ annurev.biochem.69.1.145 10966456
9. Patel MI Subbaramaiah K Du B Chang M Yang P Newman RA Cordon-Cardo C Thaler HT Dannenberg AJ Celecoxib inhibits prostate cancer growth: evidence of a cyclooxygenase-2-independent mechanism Clin Cancer Res 2005, 11(5):1999-2007 10.1158/1078-0432.CCR-04-1877 15756026
10. Tang TC Poon RT Lau CP Xie D Fan ST Tumor cyclooxygenase-2 levels correlate with tumor invasiveness in human hepatocellular carcinoma World J Gastroenterol 2005, 11(13):1896-1902 15800977
11. Dai Y Zhang X Peng Y Wang Z The expression of cyclooxygenase-2, VEGF and PGs in CIN and cervical carcinoma Gynecol Oncol 2005, 97(1):96-103 10.1016/j.ygyno.2004.12.020 15790444
12. Soumaoro LT Uetake H Higuchi T Takagi Y Enomoto M Sugihara K Cyclooxygenase-2 expression: A significant prognostic indicator for patients with colorectal cancer Clin Cancer Res 2004, 10(24):8465-8471 10.1158/1078-0432.CCR-04-0653 15623626
13. Williams CS Sheng H Brockman JA Armandla R Shao J Washington MK Elkahloun AG DuBois RN A cyclooxygenase-2 inhibitor (SC-58125) blocks growth of established human colon cancer xenografts Neoplasia 2001, 3(5):428-436 1506203 11687954 10.1038/sj.neo.7900177
14. Kojima M Morisaki T Uchiyama A Doi F Mibu R Katano M Tanaka M Association of enhanced cyclooxygenase-2 expression with possible local immunosuppression in human colorectal carcinomas Ann Surg Oncol 2001, 8(5):458-465 10.1007/s10434-001-0458-x 11407522
15. Yao M Zhou W Sangha S Albert A Chang AJ Liu TC Wolfe MM Effects of nonselective cyclooxygenase inhibition with low-dose ibuprofen on tumor growth, angiogenesis, metastasis, and survival in a mouse model of colorectal cancer Clin Cancer Res 2005, 11(4):1618-1628 10.1158/ 1078-0432.CCR-04-1696 15746067
16. Evans DM Sloan Stakleff KD Control of pulmonary metastases of rat mammary cancer by inhibition of uPA and COX-2, singly and in combination Clin Exp Metastasis 2004, 21(4):339-346 10.1023/ B:CLIN.0000046140.19131.19 15554390
17. Steinbach G Lynch PM Phillips RK Wallace MH Hawk E Gordon GB Wakabayashi N Saunders B Shen Y Fujimura T Su LK Levin B The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis N Engl J Med 2000, 342(26):1946-1952 10.1056/NEJM200006293422603 10874062
18. Arun B Goss P The role of COX-2 inhibition in breast cancer treatment and prevention Semin Oncol 2004, 31(2 Suppl 7):22-29 10.1053/ j.seminoncol.2004.03.042 15179621
19. Takahashi K Saishin Y Mori K Ando A Yamamoto S Oshima Y Nambu H Melia MB Bingaman DP Campochiaro PA Topical nepafenac inhibits ocular neovascularization Invest Ophthalmol Vis Sci 2003, 44(1):409-415 10.1167/ iovs.02-0346 12506103
20. Kapin MA Yanni JM Brady MT McDonough TJ Flanagan JG Rawji MH Dahlin DC Sanders ME Gamache DA Inflammation-mediated retinal edema in the rabbit is inhibited by topical nepafenac Inflammation 2003, 27(5):281-291 10.1023/A:1026024409826 14635785
21. Marshall JC Caissie AL Callejo SA Antecka E Burnier Jr MN Cell proliferation profile of five human uveal melanoma cell lines of different metastatic potential Pathobiology 2004, 71(5):241-245 10.1159/ 000080057 15459482
22. Diebold Y Blanco G Saornil MA Fernandez N Lazaro MC Morphologic and immunocytochemical characterization of four human uveal cell lines (melanoma- and melanocytes-derived) Curr Eye Res 1997, 16(5):487-495 10.1076/ceyr.16.5.487.7047 9154388
23. De Waard-Siebinga I Blom DJ Griffioen M Schrier PI Hoogendoorn E Beverstock G Danen EH Jager MJ Establishment and characterization of an uveal-melanoma cell line Int J Cancer 1995, 62(2):155-161 10.1002/ ijc.2910620208 7622289
24. de Souza Filho JP Correa ZM Marshall JC Anteka E Coutinho AB Martins MC Burnier MN The effect of a selective cyclooxygenase-2 (COX-2) inhibitor on the proliferation rate of retinoblastoma cell lines Eye 2006, 20(5):598-601 10.1038/sj.eye.6701938 16123787
25. Skehan P Storeng R Scudiero D Monks A McMahon J Vistica D Warren JT Bokesch H Kenney S Boyd MR New colorimetric cytotoxicity assay for anticancer-drug screening J Natl Cancer Inst 1990, 82(13):1107-1112 10.1093/jnci/82.13.1107 2359136
26. Gamache DA Graff G Brady MT Spellman JM Yanni JM Nepafenac, a unique nonsteroidal prodrug with potential utility in the treatment of trauma-induced ocular inflammation: I. Assessment of anti-inflammatory efficacy Inflammation 2000, 24(4):357-370 10.1023/A:1007049015148 10850857
27. Marshall JC Pardo M Caissie AL Callejo SA Burnier MN Cell proliferation profile of five human uveal melanoma cell lines of different metastatic potential Invest Ophthalmol Vis Sci 2002, 43:1127 11923256
28. Dandekar DS Lokeshwar BL Inhibition of cyclooxygenase (COX)-2 expression by Tet-inducible COX-2 antisense cDNA in hormone-refractory prostate cancer significantly slows tumor growth and improves efficacy of chemotherapeutic drugs Clin Cancer Res 2004, 10(23):8037-8047 10.1158/ 1078-0432.CCR-04-1208 15585639
29. Liu W Chen Y Wang W Keng P Finkelstein J Hu D Liang L Guo M Fenton B Okunieff P Ding I Combination of radiation and celebrex (celecoxib) reduce mammary and lung tumor growth Am J Clin Oncol 2003, 26(4):S103-9 10.1097/00000421-200308002-00013 12902866
30. Zha S Yegnasubramanian V Nelson WG Isaacs WB De Marzo AM Cyclooxygenases in cancer: Progress and perspective Cancer Lett 2004, 215(1):1-20 10.1016/j.canlet.2004.06.014 15374627
31. Lin HP Kulp SK Tseng PH Yang YT Yang CC Chen CS Growth inhibitory effects of celecoxib in human umbilical vein endothelial cells are mediated through G1 arrest via multiple signaling mechanisms Mol Cancer Ther 2004, 3(12):1671-1680 15634661
32. Yang HM Kim HS Park KW You HJ Jeon SI Youn SW Kim SH Oh BH Lee MM Park YB Walsh K Celecoxib, a cyclooxygenase-2 inhibitor, reduces neointimal hyperplasia through inhibition of Akt signaling Circulation 2004, 110(3):301-308 10.1161/01.CIR.0000135467.43430.16 15238462
33. Eisengart CA Mestre JR Naama HA Mackrell PJ Rivadeneira DE Murphy EM Stapleton PP Daly JM Prostaglandins regulate melanoma-induced cytokine production in macrophages Cell Immunol 2000, 204(2):143-149 10.1006/ cimm.2000.1686 11069722
34. Matsuura M Saito S Hirai Y Okamura H A pathway through interferon-gamma is the main pathway for induction of nitric oxide upon stimulation with bacterial lipopolysaccharide in mouse peritoneal cells Eur J Biochem 2003, 270(19):4016-4025 10.1046/j.1432-1033.2003.03792.x 14511384
35. Cools-Lartigue J Marshall JC Caissie AL Saraiva VS Burnier MN Jr. Secretion of hepatocyte growth factor and vascular endothelial growth factor during uveal melanoma-monocyte in vitro interactions Melanoma Res 2005, 15(3):141-145 10.1097/00008390-200506000-00001 15917694
36. Cools-Lartigue J Marshall JC Caissie AL Saraiva VS Burnier MN Jr. Secretion of interleukin-6 and prostaglandin E(2) during uveal melanoma-monocyte in vitro interactions Exp Eye Res 2004, 79(4):451-454 10.1016/j.exer.2004.05.015 15381029
37. Callejo SA Marshall JC Cools-Lartigue J Saraiva VS Burnier MN Jr. Macrophage-derived soluble factor enhances melanoma inhibitory activity expression by uveal melanoma cells in vitro Melanoma Res 2004, 14(2):91-95 10.1097/00008390-200404000-00003 15057037
38. Graham DJ Campen D Hui R Spence M Cheetham C Levy G Shoor S Ray WA Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: Nested case-control study Lancet 2005, 365(9458):475-481 15705456